Latest News & Features
Americas
A proposed judgment by the rivals would extend the period in which Mylan is barred from obtaining regulatory approval for its generic of the weight-loss injectable. 13 March 2026
Big Pharma
Research from the International Trademark Association finds in-house counsel taking on more strategic work while facing shrinking budgets, prompting a shift towards alternative billing and greater use of AI. 13 March 2026
Americas
The event unpacked how technology, litigation trends, and global events are adding complexity while also offering benefits for legal teams under pressure to reduce costs. 12 March 2026
Americas
The pharma company has successfully enforced its patents against Ascent’s proposed mirabegron copy, shortly after inking licensing deals elsewhere over the medication. 12 March 2026
Careers
With life sciences companies increasingly reliant on complex IP and licensing deals, the firm’s new hire is set to strengthen its technology transactions practice. 12 March 2026
Americas
In the deal worth up to $690 million for GSK, Italy-headquartered Alfasigma will acquire worldwide rights to linerixibat pending FDA approval. 11 March 2026
Careers
New counsel joins the firm from Kirkland & Ellis, bringing more than a decade of experience across advanced technology sectors. 10 March 2026
Americas
The telehealth platform’s shares jumped more than 40% after the news that it will sell Ozempic and Wegovy—and no longer faces a lawsuit from the Danish pharma giant. 10 March 2026
Big Pharma
UK government funding will support the London-based IP crime unit until 2029, as EUIPO and European authorities step up efforts to tackle unsafe counterfeits. 10 March 2026
Americas
Appeals court upholds lower court’s ruling, clarifying key legal questions concerning patent claims for blood‑testing devices. 9 March 2026